John Hayes, MD
Radiation Oncology · Salt Lake City, UTNPI 1275672933
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $489 and has fallen 73.6% since, to $129 in 2025.
Across 36 payments — averaging $40.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$302
- Reflexion Medical, Inc.$269
- Accuray Incorporated$154
- Varian Medical Systems, Inc.$138
- Elekta, Inc.$134
- AbbVie$99
- plus $373 from 13 others
What the payments were for
- Food & beverage$1,470100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 12 | $302 |
| Reflexion Medical, Inc. | 1 | $269 |
| Accuray Incorporated | 1 | $154 |
| Varian Medical Systems, Inc. | 1 | $138 |
| Elekta, Inc. | 1 | $134 |
| AbbVie | 6 | $99 |
| Siemens Medical Solutions USA, Inc. | 1 | $60 |
| Daiichi Sankyo Inc. | 2 | $49 |
| GT Medical Technologies, Inc | 1 | $39 |
| Pacira Pharmaceuticals Incorporated | 1 | $35 |
| Janssen Scientific Affairs, LLC | 1 | $27 |
| Pfizer | 1 | $27 |
| Merck | 1 | $26 |
| AstraZeneca | 1 | $24 |
| Johnson & Johnson | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Novocure Inc. | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,470 in reported general payments places this provider in the 85th percentile of 49 radiation oncology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alfuzosin Hcl ErAlfuzosin Hcl | 22 | $1,049 |
| Tamsulosin Hcl | 83 | $832 |
| Solifenacin Succinate | 19 | $561 |
| Bicalutamide | 16 | $415 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Salt Lake City
- Jonathan TwardSalt Lake City$114K
- David GaffneySalt Lake City$22K
- Douglas HoltSalt Lake City$3K
- Kristine KokenySalt Lake City$3K
- Matthew PoppeSalt Lake City$2K
- Shane LloydSalt Lake City$1K
- Ying HitchcockSalt Lake City$1K
- Thomas SkidmoreSalt Lake City$831
- Robert LeeSalt Lake City$752
- Amy StrowbridgeSalt Lake City$741
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.